AQR Capital Management’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

AQR Capital Management’s Portfolio NGM Stock Details NGM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-16,963	Closed	-$27K	–	2713
2024 Q1	$27K	Buy	+16,963	New	+$25.2K	﹤0.01%	2388
2023 Q1	–	Sell	-76,477	Closed	-$384K	–	2281
2022 Q4	$384K	Buy	+76,477	New	+$479K	﹤0.01%	1903
2022 Q1	–	Sell	-10,975	Closed	-$194K	–	2316
2021 Q4	$194K	Sell	10,975 -8,865	-45%	-$170K	﹤0.01%	2092
2021 Q3	$417K	Buy	+19,840	New	+$437K	﹤0.01%	1930

AQR Capital Management's NGM Position: Q2 2024 in Review

AQR Capital Management sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q2 2024, closing a stake of 16,963 shares — an estimated $27K sold.

AQR Capital Management first reported a position in NGM in Q3 2021 and held it in 4 quarters. The position peaked at $417K in Q3 2021. 0 funds tracked by Wall St. Rank hold NGM as of Q2 2024.

AQR Capital Management reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
AQR Capital Management sold 16,963 NGM Biopharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $27K.
AQR Capital Management first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
AQR Capital Management's NGM Biopharmaceuticals, Inc. Common Stock position peaked at $417K in Q3 2021.
0 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on AQR Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.